Over the years, several tumor biomarkers have been suggested to foresee the prognosis
oral squamous cell carcinoma (OSCC) patients. Here, we present a systematic review to …

Objectives We performed a systematic review to evaluate the published biomarkers related
to oral leukoplakia (OL), aiming to identify the biomarkers that indicate any future risk of …

Objectives To evaluate the current evidence in relation to the predictive value of p53
overexpression as a biomarker of the malignant transformation risk in oral potentially …

Background This meta‐analysis aimed to assess the rate of malignant transformation (MT) of
oral leukoplakia (OL) and to study potential risk factors for the MT of OL into oral squamous …

This study investigates the relevance of tumor-infiltrating lymphocytes (TILs) in oral
squamous cell carcinoma (OSCC). Immunohistochemical analysis of stromal/tumoral CD4+ …

Objective To systematically review retrospective studies examining prognostic potentials of
candidate biomarkers to stratify malignant progression of oral leukoplakia (OL) and …

Oral cancer has become one of the most aggressive types of cancer, killing 140,000 people
worldwide every year. Current treatments for oral cancer include surgery and radiation …

This scoping review aimed to map evidence regarding biomarkers for malignant
transformation of oral potentially malignant disorders (OPMD). Seventy-three longitudinal …

Podoplanin, a transmembrane sialoglycoprotein, is a specific marker for lymphatic
endothelial cells which in recent years has gained prominent notoriety for its role in tumor …

NANOG, a key regulator of pluripotency and self-renewal in embryonic and adult stem cells,
is frequently overexpressed in multiple cancers, including oral squamous cell carcinoma …